Assetmark Inc. Grows Holdings in SPDR S&P Biotech ETF $XBI

Assetmark Inc. boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,042,265.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 635,843 shares of the exchange traded fund’s stock after purchasing an additional 635,782 shares during the quarter. Assetmark Inc. owned about 0.96% of SPDR S&P Biotech ETF worth $77,528,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Legacy Bridge LLC raised its position in SPDR S&P Biotech ETF by 8.1% in the 4th quarter. Legacy Bridge LLC now owns 11,299 shares of the exchange traded fund’s stock valued at $1,378,000 after purchasing an additional 845 shares during the last quarter. High Net Worth Advisory Group LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $222,000. Valley National Advisers Inc. raised its position in SPDR S&P Biotech ETF by 14.1% in the 4th quarter. Valley National Advisers Inc. now owns 8,382 shares of the exchange traded fund’s stock valued at $1,021,000 after purchasing an additional 1,034 shares during the last quarter. U.S. Capital Wealth Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $246,000. Finally, Altfest L J & Co. Inc. raised its position in SPDR S&P Biotech ETF by 13.8% in the 4th quarter. Altfest L J & Co. Inc. now owns 142,171 shares of the exchange traded fund’s stock valued at $17,335,000 after purchasing an additional 17,250 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $132.05 on Tuesday. The company has a fifty day moving average price of $125.40 and a 200 day moving average price of $119.98. SPDR S&P Biotech ETF has a 12 month low of $73.93 and a 12 month high of $133.60. The company has a market cap of $8.51 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.